Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (585)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
164
2025
3050
11.440
Why?
Antibodies, Monoclonal
26
2024
478
5.980
Why?
Hematopoietic Stem Cell Transplantation
28
2024
605
3.180
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1025
3.140
Why?
Antineoplastic Agents
18
2024
1217
3.130
Why?
Humans
219
2025
52469
2.210
Why?
Monoclonal Gammopathy of Undetermined Significance
11
2025
125
1.990
Why?
Thalidomide
24
2024
378
1.920
Why?
Neoplasm Recurrence, Local
15
2024
638
1.720
Why?
Immunotherapy, Adoptive
9
2024
167
1.680
Why?
Killer Cells, Natural
8
2024
115
1.650
Why?
Transplantation, Autologous
26
2024
487
1.650
Why?
Gene Expression Profiling
28
2025
1108
1.600
Why?
Middle Aged
80
2025
13084
1.580
Why?
Interleukin-6
12
2023
276
1.580
Why?
Neoplasm Proteins
13
2022
328
1.510
Why?
Hematologic Neoplasms
3
2022
106
1.490
Why?
Prognosis
48
2025
2113
1.470
Why?
Aged
80
2025
10193
1.420
Why?
Antigens, Neoplasm
6
2014
147
1.370
Why?
Clinical Trials as Topic
13
2022
471
1.350
Why?
Stem Cell Transplantation
10
2022
187
1.290
Why?
B-Cell Maturation Antigen
9
2025
98
1.270
Why?
Adult
60
2025
14151
1.230
Why?
Gene Expression Regulation, Neoplastic
20
2022
853
1.210
Why?
Combined Modality Therapy
19
2024
638
1.190
Why?
Male
90
2025
26794
1.180
Why?
Chromosomes, Human, Pair 1
9
2023
96
1.180
Why?
Female
92
2025
28192
1.170
Why?
Herpesvirus 8, Human
7
2021
98
1.150
Why?
Antibodies, Bispecific
6
2025
94
1.130
Why?
Translocation, Genetic
10
2022
265
1.120
Why?
Treatment Outcome
47
2024
5471
1.070
Why?
Boronic Acids
12
2013
182
1.050
Why?
Pyrazines
12
2013
189
1.050
Why?
Bone Marrow
18
2024
363
1.000
Why?
Proteasome Inhibitors
5
2024
104
0.990
Why?
Plasma Cells
12
2025
239
0.990
Why?
Immunotherapy
6
2024
243
0.940
Why?
Neoplasms, Second Primary
2
2024
77
0.930
Why?
Disease-Free Survival
24
2019
463
0.890
Why?
B-Lymphocytes
5
2024
180
0.860
Why?
Dexamethasone
14
2024
439
0.860
Why?
T-Lymphocytes, Cytotoxic
4
2014
65
0.840
Why?
Melphalan
9
2020
181
0.830
Why?
Cancer Vaccines
3
2010
78
0.820
Why?
Follow-Up Studies
26
2024
2288
0.810
Why?
Hyperhidrosis
1
2022
2
0.780
Why?
Sweat
1
2022
9
0.770
Why?
Survival Rate
24
2020
949
0.760
Why?
Lymphoma, B-Cell
3
2022
62
0.750
Why?
Drug Approval
1
2022
43
0.740
Why?
Positron-Emission Tomography
8
2025
302
0.720
Why?
Ehrlichia chaffeensis
1
2021
4
0.710
Why?
Patient Participation
1
2022
69
0.710
Why?
T-Lymphocytes
8
2024
327
0.710
Why?
Ehrlichiosis
1
2021
14
0.700
Why?
Cryosurgery
1
2021
36
0.700
Why?
Disease Progression
17
2025
872
0.680
Why?
Immunoglobulin Light Chains
3
2017
90
0.680
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
30
0.680
Why?
Aged, 80 and over
22
2025
3413
0.670
Why?
Embolization, Therapeutic
1
2021
90
0.660
Why?
Cell Proliferation
10
2023
1024
0.650
Why?
Neoplasm, Residual
9
2025
173
0.630
Why?
Chromosomal Instability
1
2019
16
0.630
Why?
Membrane Proteins
3
2006
336
0.610
Why?
Neoplasms, Plasma Cell
3
2024
37
0.610
Why?
Survival Analysis
18
2024
671
0.610
Why?
Adrenal Cortex Hormones
2
2023
114
0.600
Why?
Immunologic Factors
2
2018
117
0.590
Why?
Epigenesis, Genetic
4
2023
403
0.570
Why?
Tumor Microenvironment
6
2024
252
0.570
Why?
Chromosome Aberrations
12
2023
297
0.570
Why?
POEMS Syndrome
1
2018
34
0.560
Why?
Dendritic Cells
3
2014
136
0.560
Why?
Atrial Fibrillation
2
2022
200
0.550
Why?
Thyroid Neoplasms
1
2019
114
0.550
Why?
Polymorphism, Single Nucleotide
3
2024
507
0.540
Why?
Prealbumin
2
2014
22
0.540
Why?
Antibodies, Monoclonal, Humanized
6
2023
235
0.520
Why?
Receptors, Interleukin-6
2
2014
23
0.510
Why?
Cardiomyopathies
2
2014
123
0.480
Why?
Mutation
10
2022
1339
0.480
Why?
Risk Assessment
11
2025
1348
0.460
Why?
Osteolysis
4
2022
75
0.460
Why?
Immunotoxins
1
2014
6
0.440
Why?
Drug Resistance, Neoplasm
7
2024
327
0.430
Why?
Recurrence
13
2024
682
0.430
Why?
Cytotoxicity, Immunologic
2
2012
57
0.430
Why?
Risk Factors
20
2025
3945
0.430
Why?
Clonal Evolution
3
2020
59
0.420
Why?
Practice Guidelines as Topic
4
2023
496
0.420
Why?
Cyclophosphamide
5
2021
172
0.410
Why?
Health Status
1
2015
299
0.400
Why?
Amyloidosis
1
2014
85
0.400
Why?
Transplantation, Homologous
5
2017
151
0.400
Why?
Thrombocytopenia
3
2025
91
0.400
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.390
Why?
Fluorodeoxyglucose F18
6
2021
188
0.390
Why?
Remission Induction
13
2021
218
0.380
Why?
Genome-Wide Association Study
3
2024
184
0.370
Why?
Neutropenia
2
2023
115
0.370
Why?
Receptors, KIR
2
2008
12
0.370
Why?
Genetic Predisposition to Disease
3
2024
528
0.360
Why?
Bone Diseases
3
2021
94
0.360
Why?
Dose-Response Relationship, Drug
8
2020
1372
0.360
Why?
Pyrimidines
2
2022
199
0.350
Why?
Prospective Studies
9
2025
2449
0.350
Why?
Cytokines
3
2025
624
0.350
Why?
Lymph Nodes
5
2025
252
0.350
Why?
Azacitidine
1
2010
39
0.340
Why?
Benzamides
1
2010
50
0.340
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Histone Deacetylase Inhibitors
1
2010
57
0.330
Why?
C-Reactive Protein
6
2022
152
0.330
Why?
Prednisone
2
2021
102
0.320
Why?
Doxorubicin
6
2021
241
0.320
Why?
Drug Administration Schedule
5
2015
374
0.310
Why?
TOR Serine-Threonine Kinases
2
2020
82
0.310
Why?
Chromosome Deletion
5
2023
140
0.310
Why?
Pelvis
2
2021
67
0.300
Why?
Metaphase
4
2016
46
0.300
Why?
Quality of Life
1
2015
881
0.300
Why?
Vaccination
4
2022
299
0.300
Why?
Membrane Glycoproteins
2
2009
241
0.300
Why?
Disease Management
3
2025
186
0.290
Why?
Paraproteinemias
3
2022
74
0.290
Why?
Animals
15
2024
13455
0.290
Why?
Proportional Hazards Models
7
2024
442
0.290
Why?
Placebo Effect
2
2020
16
0.280
Why?
Young Adult
8
2025
4326
0.280
Why?
Fever
3
2025
113
0.280
Why?
Bone Neoplasms
4
2013
185
0.280
Why?
Adoptive Transfer
1
2007
29
0.280
Why?
Histocompatibility Antigens Class I
1
2007
48
0.270
Why?
Chromatin
3
2023
141
0.270
Why?
CD8-Positive T-Lymphocytes
3
2024
131
0.270
Why?
Cytogenetic Analysis
5
2023
80
0.270
Why?
DNA Methylation
4
2023
583
0.260
Why?
Boron Compounds
2
2024
19
0.260
Why?
Registries
4
2025
629
0.260
Why?
Chromans
2
2024
34
0.260
Why?
Vincristine
3
2021
88
0.260
Why?
Cell Membrane
1
2007
241
0.260
Why?
Mice, SCID
6
2013
179
0.260
Why?
Glycine
2
2024
75
0.250
Why?
Angiogenesis Inhibitors
5
2010
184
0.250
Why?
Down-Regulation
1
2007
344
0.250
Why?
In Situ Hybridization, Fluorescence
5
2023
263
0.250
Why?
Neoplasm Staging
6
2024
765
0.240
Why?
Consensus
3
2025
191
0.240
Why?
Cell Line, Tumor
9
2023
1423
0.240
Why?
Vitamin E
2
2024
77
0.240
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Transplantation Conditioning
5
2008
93
0.240
Why?
Case-Control Studies
6
2024
1198
0.240
Why?
Mice
11
2024
5936
0.240
Why?
Bone Resorption
2
2022
302
0.240
Why?
Infusions, Intravenous
3
2015
220
0.230
Why?
Flow Cytometry
4
2012
400
0.230
Why?
Connective Tissue Diseases
1
2025
20
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
Why?
Time Factors
11
2021
2989
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Autoantibodies
1
2025
121
0.220
Why?
Monocytes
2
2020
129
0.210
Why?
Gene Expression
2
2018
623
0.210
Why?
High-Throughput Nucleotide Sequencing
3
2022
179
0.210
Why?
Cell Cycle Proteins
2
2022
168
0.210
Why?
Blotting, Western
3
2015
592
0.210
Why?
Epstein-Barr Virus Infections
2
2020
33
0.200
Why?
Signal Transduction
6
2021
1702
0.200
Why?
Radiation-Protective Agents
1
2024
72
0.200
Why?
Proteasome Endopeptidase Complex
3
2011
140
0.200
Why?
Integrin beta Chains
1
2023
14
0.200
Why?
Ubiquitin-Protein Ligases
1
2024
137
0.200
Why?
Integrins
1
2023
31
0.200
Why?
Retrospective Studies
11
2025
6643
0.200
Why?
Double-Blind Method
2
2015
718
0.200
Why?
Cross-Sectional Studies
3
2023
1680
0.200
Why?
Sweating
1
2022
13
0.190
Why?
Hematopoietic Stem Cells
2
2022
188
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
77
0.190
Why?
Tumor Cells, Cultured
4
2013
447
0.190
Why?
Kaplan-Meier Estimate
10
2016
483
0.190
Why?
DNA, Intergenic
1
2022
6
0.190
Why?
Proteomics
3
2021
327
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Receptors, Antigen, T-Cell
1
2022
51
0.190
Why?
Tumor Suppressor Protein p53
2
2017
224
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.180
Why?
United States
4
2022
5225
0.180
Why?
United States Food and Drug Administration
1
2022
96
0.180
Why?
Influenza, Human
1
2022
85
0.180
Why?
Mediastinum
1
2021
21
0.180
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.180
Why?
Epigenomics
1
2021
74
0.180
Why?
Receptors, Glucocorticoid
2
2012
34
0.180
Why?
Apoptosis
5
2018
1121
0.180
Why?
Phosphatidylinositol 3-Kinases
2
2019
149
0.180
Why?
Axilla
1
2021
92
0.180
Why?
Ubiquitination
1
2021
57
0.180
Why?
Alleles
3
2021
277
0.170
Why?
Multiple Organ Failure
1
2021
49
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.170
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.170
Why?
Salvage Therapy
6
2013
136
0.170
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.170
Why?
Adolescent
7
2025
6708
0.170
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.170
Why?
Rare Diseases
1
2020
47
0.170
Why?
Interferon-gamma
3
2014
179
0.170
Why?
Transcriptome
5
2025
367
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Radiopharmaceuticals
4
2021
204
0.170
Why?
Cell Cycle
1
2021
238
0.170
Why?
Longitudinal Studies
5
2024
746
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Interferon Type I
1
2020
28
0.160
Why?
Myelodysplastic Syndromes
2
2013
85
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
Research Design
2
2020
358
0.160
Why?
Multivariate Analysis
8
2021
602
0.160
Why?
ROC Curve
2
2025
253
0.160
Why?
Genomics
4
2023
270
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
DNA
1
2023
548
0.160
Why?
Measles virus
1
2019
8
0.160
Why?
Measles
1
2019
7
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Data Collection
1
2020
289
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Immunohistochemistry
2
2015
980
0.160
Why?
Oncolytic Virotherapy
1
2019
21
0.150
Why?
Health Status Disparities
1
2022
216
0.150
Why?
Biopsy
5
2018
602
0.150
Why?
Patient Safety
1
2020
103
0.150
Why?
Sirolimus
1
2019
72
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Cell Differentiation
6
2022
673
0.150
Why?
Precancerous Conditions
2
2010
85
0.150
Why?
Evidence-Based Medicine
2
2018
269
0.150
Why?
Healthcare Disparities
1
2022
300
0.150
Why?
Syndrome
1
2019
252
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
170
0.150
Why?
MafB Transcription Factor
1
2018
9
0.150
Why?
Spleen
1
2019
170
0.150
Why?
Graft vs Host Disease
4
2007
88
0.150
Why?
Genomic Instability
2
2016
89
0.140
Why?
Immunomodulation
1
2018
37
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Chemokines
1
2018
78
0.140
Why?
Plasma
1
2018
46
0.140
Why?
Myeloablative Agonists
2
2008
32
0.140
Why?
Hematopoietic Stem Cell Mobilization
2
2008
60
0.140
Why?
Osteoclasts
3
2022
428
0.140
Why?
Genes, Neoplasm
2
2015
31
0.140
Why?
Magnetic Resonance Imaging
5
2013
1536
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Models, Biological
2
2018
739
0.140
Why?
Gene Dosage
2
2015
78
0.140
Why?
Gene Rearrangement
1
2018
76
0.140
Why?
Hexokinase
1
2017
16
0.130
Why?
Communication
1
2019
257
0.130
Why?
Heterozygote
2
2014
91
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Protein-Tyrosine Kinases
2
2018
89
0.130
Why?
HLA-A Antigens
2
2007
11
0.130
Why?
Drug Therapy, Combination
1
2018
399
0.130
Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.130
Why?
Gene Frequency
2
2013
99
0.120
Why?
Syndecan-1
4
2021
73
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Lymphocyte Activation
2
2017
162
0.120
Why?
Critical Illness
1
2018
312
0.120
Why?
Tumor Burden
3
2020
133
0.120
Why?
Confidence Intervals
2
2014
159
0.120
Why?
Immunity, Innate
1
2016
114
0.120
Why?
Erythrocyte Indices
1
2015
7
0.120
Why?
Biomarkers, Pharmacological
2
2012
26
0.120
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Coculture Techniques
2
2013
143
0.120
Why?
Hemoglobins
2
2013
111
0.110
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
87
0.110
Why?
International Cooperation
1
2014
52
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
236
0.110
Why?
Fatigue
1
2015
129
0.110
Why?
Iron
1
2015
129
0.110
Why?
Area Under Curve
1
2014
183
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Antibodies
2
2024
150
0.110
Why?
Reference Values
1
2014
313
0.110
Why?
Emotions
1
2015
172
0.100
Why?
Antineoplastic Agents, Alkylating
3
2008
77
0.100
Why?
Renal Insufficiency
2
2021
114
0.100
Why?
Disease Models, Animal
2
2016
1480
0.100
Why?
Severity of Illness Index
2
2014
1038
0.100
Why?
Neoplasms, Glandular and Epithelial
1
2014
42
0.100
Why?
Administration, Metronomic
1
2013
7
0.100
Why?
Inflammation Mediators
1
2014
116
0.100
Why?
Cystatin M
2
2024
19
0.100
Why?
Cisplatin
4
2013
284
0.100
Why?
Macaca mulatta
2
2024
93
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
beta Catenin
1
2013
103
0.100
Why?
Central Nervous System Neoplasms
1
2013
69
0.100
Why?
Oligopeptides
1
2013
92
0.100
Why?
Venous Thrombosis
2
2004
90
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Edema
2
2025
65
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Cell Survival
2
2020
600
0.100
Why?
Pain
1
2015
359
0.100
Why?
Mental Health
1
2015
240
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
76
0.090
Why?
Maintenance Chemotherapy
1
2012
51
0.090
Why?
Vascular Endothelial Growth Factor A
1
2013
187
0.090
Why?
Adaptor Proteins, Signal Transducing
2
2024
200
0.090
Why?
Models, Genetic
2
2016
172
0.090
Why?
Interleukin-2
1
2012
69
0.090
Why?
Mice, Inbred NOD
1
2012
91
0.090
Why?
Immunoenzyme Techniques
1
2012
136
0.090
Why?
Cell Movement
1
2013
273
0.090
Why?
Hemangioma
1
2013
85
0.090
Why?
Soft Tissue Neoplasms
1
2012
55
0.090
Why?
Immunoglobulin G
2
2025
195
0.090
Why?
Arkansas
5
2021
2024
0.090
Why?
Genotype
1
2013
571
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
44
0.090
Why?
Models, Statistical
2
2014
230
0.090
Why?
Chemokine CXCL13
2
2022
6
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
59
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.080
Why?
Hypersensitivity, Delayed
1
2010
18
0.080
Why?
CD40 Ligand
1
2010
15
0.080
Why?
Interleukin-4
1
2010
43
0.080
Why?
Secondary Prevention
1
2010
85
0.080
Why?
Up-Regulation
4
2018
462
0.080
Why?
HIV Seropositivity
1
2010
28
0.080
Why?
Eukaryotic Initiation Factor-2
1
2010
17
0.080
Why?
Immunity, Cellular
1
2010
64
0.080
Why?
Adjuvants, Immunologic
1
2010
52
0.080
Why?
Cell Line
2
2013
1030
0.080
Why?
Cells, Cultured
3
2013
1586
0.080
Why?
Ovarian Neoplasms
1
2014
460
0.080
Why?
Etoposide
2
2007
71
0.080
Why?
Transplantation, Heterologous
1
2009
78
0.080
Why?
Placenta
1
2011
152
0.080
Why?
Radiography
4
2012
474
0.080
Why?
Polymerase Chain Reaction
1
2010
459
0.080
Why?
Histones
2
2021
316
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.070
Why?
Transcription Factors
2
2023
566
0.070
Why?
Hospitalization
2
2024
749
0.070
Why?
Liver Neoplasms
1
2012
333
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Bone and Bones
3
2021
494
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
64
0.070
Why?
Haplotypes
1
2008
95
0.070
Why?
Gene Deletion
1
2009
275
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Neoplastic Stem Cells
1
2009
90
0.070
Why?
Ligands
1
2008
207
0.070
Why?
Receptors, Immunologic
1
2008
36
0.070
Why?
Osteogenesis
1
2011
366
0.070
Why?
Twins
1
2007
33
0.070
Why?
Busulfan
1
2007
17
0.070
Why?
Diphosphonates
1
2008
92
0.070
Why?
Herpesviridae Infections
2
2019
57
0.070
Why?
Immunophenotyping
1
2007
117
0.070
Why?
Leukocytes, Mononuclear
1
2007
122
0.070
Why?
Caspases
2
2018
102
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Skin Neoplasms
1
2012
500
0.070
Why?
Creatinine
1
2007
159
0.060
Why?
Blood Proteins
1
2007
84
0.060
Why?
Antibodies, Neoplasm
1
2006
27
0.060
Why?
Graft vs Leukemia Effect
1
2006
2
0.060
Why?
Immunosuppressive Agents
1
2008
250
0.060
Why?
Plasmacytoma
1
2006
43
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Cohort Studies
3
2020
1550
0.060
Why?
MicroRNAs
1
2010
385
0.060
Why?
Amiloride
1
2005
7
0.060
Why?
Bone Marrow Transplantation
2
2022
113
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Imaging, Three-Dimensional
2
2017
151
0.060
Why?
Decision Trees
1
2025
22
0.060
Why?
Sensitivity and Specificity
1
2007
883
0.060
Why?
Child
3
2025
7188
0.060
Why?
Tomography, X-Ray Computed
2
2023
1162
0.060
Why?
Predictive Value of Tests
3
2018
944
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
30
0.060
Why?
Japan
1
2025
38
0.060
Why?
Autoantigens
1
2025
50
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
3
0.060
Why?
Piperidones
1
2024
7
0.060
Why?
Enoxaparin
1
2004
31
0.060
Why?
Telomere
1
2024
38
0.050
Why?
Retreatment
1
2024
58
0.050
Why?
Morpholines
1
2024
65
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
NF-kappa B
2
2018
329
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
Why?
Neoplasms
1
2014
1302
0.050
Why?
Epidemiologic Methods
3
2008
46
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Gene Silencing
2
2016
120
0.050
Why?
Fibroblasts
1
2005
359
0.050
Why?
Cluster Analysis
3
2010
232
0.050
Why?
Cell Communication
1
2023
72
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
66
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Whole-Body Irradiation
1
2022
128
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Phenotype
1
2025
799
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Primary Cell Culture
1
2022
62
0.050
Why?
Risk
2
2014
313
0.050
Why?
Patient Selection
1
2023
266
0.050
Why?
Quantitative Trait Loci
1
2022
51
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Anticoagulants
1
2004
277
0.040
Why?
Age of Onset
2
2013
110
0.040
Why?
Phylogeny
1
2022
234
0.040
Why?
Child, Preschool
2
2020
4034
0.040
Why?
RANK Ligand
1
2022
187
0.040
Why?
Rabbits
2
2013
373
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Polymorphism, Genetic
1
2022
184
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
68
0.040
Why?
Base Sequence
1
2022
634
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Fibrosis
1
2021
197
0.040
Why?
Repressor Proteins
1
2022
153
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
63
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Protein Kinase Inhibitors
1
2022
226
0.040
Why?
Single-Cell Analysis
1
2020
73
0.040
Why?
Genetic Loci
1
2020
49
0.040
Why?
Mice, Transgenic
1
2021
563
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Neoplasm Invasiveness
1
2020
277
0.040
Why?
Genetic Variation
1
2020
229
0.040
Why?
Incidence
2
2013
1076
0.040
Why?
Europe
1
2019
91
0.040
Why?
Herpesvirus 4, Human
1
2019
44
0.040
Why?
Communicable Disease Control
1
2019
37
0.040
Why?
Computational Biology
1
2020
211
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
Genome, Viral
1
2019
83
0.040
Why?
DNA, Viral
1
2019
137
0.040
Why?
RNA, Messenger
2
2016
1139
0.040
Why?
Virus Diseases
1
2019
46
0.040
Why?
Fibrinogen
1
2018
34
0.040
Why?
Immunoglobulin A
1
2018
46
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
DNA-Binding Proteins
1
2021
425
0.040
Why?
Platelet Count
2
2008
76
0.040
Why?
Promoter Regions, Genetic
1
2020
474
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Pathology, Molecular
1
2018
28
0.040
Why?
Oncogene Proteins, Fusion
1
2018
60
0.030
Why?
Data Interpretation, Statistical
2
2010
164
0.030
Why?
Databases, Factual
2
2013
715
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Glomerular Filtration Rate
1
2017
129
0.030
Why?
Cell Transformation, Neoplastic
1
2018
184
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Internationality
1
2017
46
0.030
Why?
Amino Acid Sequence
1
2018
571
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
78
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Proteolysis
1
2016
102
0.030
Why?
Enzyme Activation
1
2016
269
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Chromosome Mapping
2
2006
150
0.030
Why?
Prevalence
1
2019
1016
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
97
0.030
Why?
Phosphorylation
1
2016
525
0.030
Why?
Kidney Diseases
1
2017
231
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Myocardium
1
2017
478
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
6
0.030
Why?
HIV-1
1
2014
59
0.030
Why?
Homozygote
1
2013
58
0.030
Why?
Cerebrospinal Fluid
1
2013
29
0.030
Why?
Genetic Vectors
1
2014
130
0.030
Why?
Diagnosis, Differential
1
2017
1044
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
8
0.030
Why?
Receptors, CXCR4
1
2013
29
0.030
Why?
Dependovirus
1
2014
103
0.030
Why?
Niacinamide
1
2013
24
0.030
Why?
Enzyme Induction
1
2013
76
0.030
Why?
NAD
1
2013
45
0.030
Why?
Amides
1
2013
37
0.030
Why?
Nitriles
1
2013
51
0.030
Why?
Sirtuin 1
1
2013
29
0.020
Why?
Chemokine CXCL12
1
2013
34
0.020
Why?
Gene Knockdown Techniques
1
2013
109
0.020
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
RNA, Small Interfering
1
2013
217
0.020
Why?
Piperidines
1
2013
96
0.020
Why?
Infant
1
2020
3691
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Induction Chemotherapy
1
2012
64
0.020
Why?
Acute Disease
1
2013
387
0.020
Why?
Chemokine CXCL10
1
2011
20
0.020
Why?
HIV Infections
1
2016
388
0.020
Why?
Antibodies, Neutralizing
1
2011
79
0.020
Why?
Sex Factors
1
2013
731
0.020
Why?
Pharmacogenetics
1
2011
51
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
24
0.020
Why?
Enzyme Inhibitors
1
2013
371
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
47
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
Why?
Microarray Analysis
1
2010
69
0.020
Why?
International Classification of Diseases
1
2010
67
0.020
Why?
Argonaute Proteins
1
2010
12
0.020
Why?
RNA-Binding Proteins
1
2011
134
0.020
Why?
Oligonucleotides
1
2010
76
0.020
Why?
Polyploidy
1
2009
9
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
71
0.020
Why?
Neoplasm Metastasis
1
2009
237
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Polyethylene Glycols
1
2008
91
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
217
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
599
0.020
Why?
Age Distribution
1
2007
175
0.020
Why?
Recombinant Proteins
1
2008
495
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
53
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
87
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
201
0.010
Why?
Brain
1
2013
1321
0.010
Why?
Survivors
1
2006
118
0.010
Why?
Pregnancy
1
2011
2670
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
173
0.010
Why?
Administration, Oral
1
2003
455
0.010
Why?
Tissue Donors
1
2003
124
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description